Fluticasone furoate and vilanterol for COPD - authors' reply

Lancet Respir Med. 2013 Jul;1(5):e21-2. doi: 10.1016/S2213-2600(13)70125-5. Epub 2013 Jul 8.

Authors

Mark T Dransfield¹, Sally Lettis², Frank Barnhart³, Courtney Crim³, Peter M A Calverley⁴

Affiliations

¹ AB Lung Health Center Division of Pulmonary, Allergy and Critical Care Medicine University of Alabama at Birmingham & Birmingham VA Medical Center, Birmingham, AL 35294, USA. Electronic address: mdransfield99@msn.com.
² GlaxoSmithKline, London, UK.
³ GlaxoSmithKline, Research Triangle Park, NC, USA.
⁴ University of Liverpool, Liverpool, UK.

PMID: 24429207
DOI: 10.1016/S2213-2600(13)70125-5

No abstract available

Publication types

Letter
Comment

MeSH terms

Androstadienes*
Benzyl Alcohols*
Chlorobenzenes*
Female
Humans
Male
Pneumonia*
Pulmonary Disease, Chronic Obstructive / drug therapy*
Respiratory System / drug effects*

Substances

Androstadienes
Benzyl Alcohols
Chlorobenzenes